XPhyto Therapeutics (XPHY.C) announced today that its Good Manufacturing Practice (GMP) mescaline synthesis program is on schedule with the completion of initial production batches. “With both its North…
Pharmaceuticals
The New York Times went viral (shocker) in 2015 with their article covering psychologist Arthur Aron’s study on 36 questions that lead to love. #6 is the following: “If…
Tetra Bio-Pharma (TBP.T) announced today that Health Canada has accepted the Company’s New Drug Submission (NDS) for REDUVO™ and has formally entered the final review phase in the drug…
On May 31, 2021 Aequus Pharmaceuticals (AQS.V) reported financial results for Q1, 2021. Aequus is a $19 million pharmaceutical company focused on developing and commercializing high quality, differentiated…
Anyone else watching charts trend downwards? Yeah. There’s a reason that junior market traders hold tight to the saying of “May: sell and go away”, but ‘May’ started unusually…
Khiron Life Sciences (KHRN.V) announced today that it has partnered with the Colombia Cancer League (CCL) to launch the “Cannabis: Medicine for Your Life” campaign throughout Columbia. In collaboration…
XPhyto Therapeutics (XPHY.C), a bioscience accelerator in the life science industry, announced today that its drug formulation programs are advancing on schedule and continue to expand in scope. “Vektor…
Tetra Bio-Pharma (TBP.T) has announced the start of the REBORN1© clinical trial, designed to evaluate the effect of QIXLEEF™, the Company’s inhaled proprietary drug formulation. During this study, QIXLEEF™…
Tetra Bio-Pharma (TBP.T), a leader in cannabinoid-derived drug discovery and development, has announced that is has signed a Definitive Agreement with DanCann Pharma for the exclusive distribution of Reduvo™…
Another day, another Tetra Bio-Pharma (TBP.T) news release. A day after they were granted a Drug Establishment Licence by Health Canada for their REDUVO soft gel capsules, Tetra announced…